Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

SHAPE-ENDO (Strategic Hormonal Approach & Prehabilitation in Endometrial Cancer): Prospective Observational Study for Metabolic and Surgical Optimization in Patients With Atypical Endometrial Hyperplasia or Early-stage Endometrial Cancer and BMI ≥40 kg/m2. (Phase 1)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07462663
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:03.767076+00:00
Published At
2026-04-23T00:00:00+00:00
Record Updated At
2026-04-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Endometrial Cancer", "Endometrial Cancer Stage I", "Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I", "Atypical Endometrial Hyperplasia", "Endometrial Intraepithelial Neoplasia", "Obesity \u0026 Overweight", "BMI\u003e40", "Obesity", "Obesity Grade III"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-23"
protocolSection.identificationModule.nctId
"NCT07462663"
protocolSection.identificationModule.officialTitle
"SHAPE-ENDO (Strategic Hormonal Approach \u0026 Prehabilitation in Endometrial Cancer): Prospective Observational Study for Metabolic and Surgical Optimization in Patients With Atypical Endometrial Hyperplasia or Early-stage Endometrial Cancer and BMI \u226540 kg/m2. (Phase 1)"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Endometrial Cancer (protocolSection.conditionsModule.conditions)
  • Endometrial Cancer Stage I (protocolSection.conditionsModule.conditions)
  • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I (protocolSection.conditionsModule.conditions)
  • Atypical Endometrial Hyperplasia (protocolSection.conditionsModule.conditions)
  • Endometrial Intraepithelial Neoplasia (protocolSection.conditionsModule.conditions)
  • Obesity & Overweight (protocolSection.conditionsModule.conditions)
  • BMI>40 (protocolSection.conditionsModule.conditions)
  • Obesity (protocolSection.conditionsModule.conditions)
  • Obesity Grade III (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.